February 12, 2026- Medela announced that its Thopaz+ Digital Chest Drainage System has been awarded a contract by Vizient, Inc. Thopaz+ is the first system awarded in Vizient’s newly created digital chest drainage category, reflecting the growing role of digital technologies in improving clinical decision-making and patient outcomes following cardiothoracic procedures. Through this agreement, Vizient provider clients will now have access to enhanced savings and negotiated terms and conditions for the Thopaz+ Digital Chest Drainage System.
Thopaz+ is a digital chest drainage and monitoring system designed to support patients following cardiothoracic procedures. Unlike traditional analog systems that rely on visual interpretation of bubbling and fluid columns, Thopaz+ uses precise digital technology to apply and maintain consistent, regulated negative pressure while continuously monitoring air leak and fluid drainage.